Cargando…
Acquired activated protein C resistance and thrombosis in multiple myeloma patients
BACKGROUND: An increased incidence of deep venous thrombosis (DVT) has been described in multiple myeloma (MM). A recently described mechanism of hypercoagulability in cancer patients including MM patients is acquired activated protein C resistance (APC-R). The purpose of the present study was to ex...
Autores principales: | Hugo, Jiménez-Zepeda Víctor, Jeanet, Domínguez-Martínez Virginia |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1564129/ https://www.ncbi.nlm.nih.gov/pubmed/16923190 http://dx.doi.org/10.1186/1477-9560-4-11 |
Ejemplares similares
-
Genetic aberrations in multiple myeloma characterized by cIg-FISH: a
Brazilian context
por: Segges, P., et al.
Publicado: (2016) -
Pharmacovigilance of patients with multiple myeloma being treated with bortezomib and/or thalidomide
por: Castro, T.B.M., et al.
Publicado: (2016) -
Changes in circulating endothelial progenitor cells predict responses of
multiple myeloma patients to treatment with bortezomib and
dexamethasone
por: Wang, L., et al.
Publicado: (2015) -
Chromosomal instability and acquired drug resistance in multiple myeloma
por: Wang, Wang, et al.
Publicado: (2017) -
Evaluation of a Motion Correction Algorithm for C-Arm Computed Tomography Acquired During Transarterial Chemoembolization
por: Becker, Lena S., et al.
Publicado: (2020)